CIK 0001818382
- Non-accelerated filer
- Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851763759
- Phone
- +1 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 4 Open-market buy CFO and Chief Corp. Deve. Off. bought 20,000 shares at $2.60 ($52,000)
- 4 Open-market buy President, CEO and Director bought 10,000 shares at $2.54 ($25,400)
- 4 Open-market buy Director bought 10,000 shares at $2.54 ($25,400)
- 4 Open-market sale President, CEO and Director sold 239,538 shares at $2.53 ($606,031)
- 4 Open-market sale Director sold 239,538 shares at $2.53 ($606,031)
- 4 Open-market sale 10% owner sold 239,538 shares at $2.53 ($606,031)
- 4 Open-market buy Chief Commercial Officer bought 5,000 shares at $3.09 ($15,450)
- 4 Open-market sale President, CEO and Director sold 699,730 shares at an average $2.78 ($1,945,509)
- 4 Open-market sale Director sold 699,730 shares at an average $2.78 ($1,945,509)
- 4 Open-market sale 10% owner sold 699,730 shares at an average $2.78 ($1,945,509)
- 4 Exercise or conversion Chief Operating Officer acquired 6,564 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President, CEO and Director bought 2,000 shares at $4.14 ($8,280)
Page 8 of 12 · 235 filings